Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A module map showing conditional activity of expression modules in cancer

Abstract

DNA microarrays are widely used to study changes in gene expression in tumors, but such studies are typically system-specific and do not address the commonalities and variations between different types of tumor. Here we present an integrated analysis of 1,975 published microarrays spanning 22 tumor types. We describe expression profiles in different tumors in terms of the behavior of modules, sets of genes that act in concert to carry out a specific function. Using a simple unified analysis, we extract modules and characterize gene-expression profiles in tumors as a combination of activated and deactivated modules. Activation of some modules is specific to particular types of tumor; for example, a growth-inhibitory module is specifically repressed in acute lymphoblastic leukemias and may underlie the deregulated proliferation in these cancers. Other modules are shared across a diverse set of clinical conditions, suggestive of common tumor progression mechanisms. For example, the bone osteoblastic module spans a variety of tumor types and includes both secreted growth factors and their receptors. Our findings suggest that there is a single mechanism for both primary tumor proliferation and metastasis to bone. Our analysis presents multiple research directions for diagnostic, prognostic and therapeutic studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Overview of the analysis procedure.
Figure 2: The cancer module map: a matrix of modules (rows) versus array clinical conditions (columns), where a red (or green) entry indicates that the arrays in which the corresponding module was significantly induced (or repressed) contained more arrays with the given annotation than would be expected by chance.
Figure 3: Combinatorial signatures in the cancer module map.
Figure 4: Growth inhibitory module (#173), a module that responds significantly to one specific condition: acute leukemia.
Figure 5: Steroid catabolism module (#505), a module that responds significantly to one specific condition: liver tissue and tumor samples.
Figure 6: Bone osteoblastic module (#234), a module that responds significantly to multiple conditions, including breast cancer, lung cancer, HCC and ALL.

Similar content being viewed by others

References

  1. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54 (2003).

    Article  CAS  Google Scholar 

  2. Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149–15154 (2001).

    Article  CAS  Google Scholar 

  3. Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323–334 (2003).

    Article  CAS  Google Scholar 

  4. Rhodes, D.R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101, 9309–9314 (2004).

    Article  CAS  Google Scholar 

  5. Mootha, V.K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–723 (2003).

    Article  CAS  Google Scholar 

  6. Su, A.I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99, 4465–4470 (2002).

    Article  CAS  Google Scholar 

  7. Kanehisa, M., Goto, S., Kawashima, S. & Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res. 30, 42–46 (2002).

    Article  CAS  Google Scholar 

  8. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).

    Article  CAS  Google Scholar 

  9. Dahlquist, K.D., Salomonis, N., Vranizan, K., Lawlor, S.C. & Conklin, B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31, 19–20 (2002).

    Article  CAS  Google Scholar 

  10. Kim, S.C. et al. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93, 3893–3899 (1999).

    CAS  PubMed  Google Scholar 

  11. Chu, Y., Solski, P.A., Khosravi-Far, R., Der, C.J. & Kelly, K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271, 6497–6501 (1996).

    Article  CAS  Google Scholar 

  12. Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S. & Horii, A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162, 1807–1815 (2003).

    Article  CAS  Google Scholar 

  13. Leone, A.M., Errico, M., Lin, S.L. & Cowen, D.S. Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4. J. Neurochem. 75, 934–938 (2000).

    Article  CAS  Google Scholar 

  14. Shi, C.S. et al. Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation. J. Biol. Chem. 276, 24293–24300 (2001).

    Article  CAS  Google Scholar 

  15. Ge, B. et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J. Biol. Chem. 278, 2286–2293 (2003).

    Article  CAS  Google Scholar 

  16. Mita, H., Tsutsui, J., Takekawa, M., Witten, E.A. & Saito, H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22, 4544–4555 (2002).

    Article  CAS  Google Scholar 

  17. Granata, O.M. et al. Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness. Mol. Cell. Endocrinol. 193, 51–58 (2002).

    Article  CAS  Google Scholar 

  18. Mundy, G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2, 584–593 (2002).

    Article  CAS  Google Scholar 

  19. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–459 (2003).

    Article  CAS  Google Scholar 

  20. Iguchi, H. et al. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 21, 309–313 (2002).

    CAS  PubMed  Google Scholar 

  21. Boot, A.M., van den Heuvel-Eibrink, M.M., Hahlen, K., Krenning, E.P. & de Muinck Keizer-Schrama, S.M. Bone mineral density in children with acute lymphoblastic leukaemia. Eur. J. Cancer 35, 1693–1697 (1999).

    Article  CAS  Google Scholar 

  22. Ugolini, F. et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18, 1903–1910 (1999).

    Article  CAS  Google Scholar 

  23. Reinholz, M.M., Iturria, S.J., Ingle, J.N. & Roche, P.C. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res. Treat. 74, 255–269 (2002).

    Article  CAS  Google Scholar 

  24. Bernards, R. & Weinberg, R.A. A progression puzzle. Nature 418, 823 (2002).

    Article  CAS  Google Scholar 

  25. Hynes, R.O. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113, 821–823 (2003).

    Article  CAS  Google Scholar 

  26. Ferrari, N. et al. DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias. J. Leukoc. Biol. 74, 302–305 (2003).

    Article  CAS  Google Scholar 

  27. Segal, E. et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166–176 (2003).

    Article  CAS  Google Scholar 

  28. Ihmels, J. et al. Revealing modular organization in the yeast transcriptional network. Nat. Genet. 31, 370–377 (2002).

    Article  CAS  Google Scholar 

  29. Tanay, A., Sharan, R., Kupiec, M. & Shamir, R. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc. Natl. Acad. Sci. USA 101, 2981–2986 (2004).

    Article  CAS  Google Scholar 

  30. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J. Effrat, T. Fojo, Y. Friedman, A. Kaushal, W. Lu, T. Pham, M. Tong, and R. Yelensky for technical help with software and visualization and I. Ben-Porath, Y. Dor, L. Garwin, N. Kaminski, D. Pe'er, O. Rando and T. Raveh for comments on previous versions of this manuscript. E.S., N.F. and D.K. were supported by a National Science Foundation grant under the Information Technology Research program. E.S. was also supported by a Stanford Graduate Fellowship. N.F. was also supported by an Alon Fellowship, by the Harry & Abe Sherman Senior Lectureship in Computer Science and by the United States-Israel Bi-National Science Foundation grant. N.F. and A.R. were supported by a Center of Excellence Grant from the National Institute of General Medical Sciences. A.R. was also supported by the Bauer Center for Genomics Research.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Daphne Koller or Aviv Regev.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Statistical significance of the procedure for deriving a module from a gene set cluster. (PDF 88 kb)

Supplementary Fig. 2

Distribution of the significant array-gene set pairs by conditions. (PDF 106 kb)

Supplementary Table 1

Microarray data sources for the cancer compendium. (PDF 34 kb)

Supplementary Note (PDF 89 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segal, E., Friedman, N., Koller, D. et al. A module map showing conditional activity of expression modules in cancer. Nat Genet 36, 1090–1098 (2004). https://doi.org/10.1038/ng1434

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1434

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing